Literature DB >> 6452942

Protein synthesis, amino acid uptake, and pools during isoproterenol-induced hypertrophy of the rat heart and tibialis muscle.

Y Deshaies, J Willemot, J Leblanc.   

Abstract

Chronic administration of isoproterenol (ISO) produces hypertrophy of the rat heart and tibialis muscle. With doses of 0.1, 0.3, and 0.6 mg/kg, hypertrophy of the heart is significantly by the 3rd day of treatment. Maximum cardiac enlargement attained with doses of 0.3 and 0.6 mg/kg occurs after 21 days and averages 40% above control values. ISO increases tibialis muscle weight by 15%. Incorporation of 14C-labeled amino acids into total heart and tibialis muscle protein is stimulated by ISO. Maximum stimulation occurs 2-3 h after the fifth daily injection of ISO. The stimulation of incorporation is greater during the first few days of treatment and decreases gradually thereafter. A single injection of ISO decreases the total amino acid concentration of the serum, heart and tibialis muscle whereas the rate of amino acid uptake by the heart and tibialis muscle is increased by ISO. The production of hypertrophy of the heart and tibialis muscle in diabetic or castrated animals by ISO suggests that insulin and testosterone are not essential in the mechanism of ISO-induced hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6452942     DOI: 10.1139/y81-020

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  10 in total

1.  Long-term isoprenaline administration and its effect on the revascularisation and regeneration of skeletal muscle transplants in mice.

Authors:  P Roberts; J K McGeachie
Journal:  J Anat       Date:  1996-06       Impact factor: 2.610

Review 2.  Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue.

Authors:  Y T Yang; M A McElligott
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

3.  The enhancement of revascularisation of skeletal muscle transplants using the beta 2-agonist isoprenaline.

Authors:  P Roberts; J K McGeachie
Journal:  J Anat       Date:  1994-04       Impact factor: 2.610

4.  Synergistic interactions between Ca2+ entries through L-type Ca2+ channels and Na+-Ca2+ exchanger in normal and failing rat heart.

Authors:  Serge Viatchenko-Karpinski; Dmitry Terentyev; Leigh Ann Jenkins; Lorenz O Lutherer; Sandor Györke
Journal:  J Physiol       Date:  2005-06-23       Impact factor: 5.182

5.  The action of the beta-agonist clenbuterol on protein metabolism in innervated and denervated phasic muscles.

Authors:  C A Maltin; S M Hay; M I Delday; G E Lobley; P J Reeds
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

6.  Ractopamine-induced fiber type-specific gene expression in porcine skeletal muscles is independent of growth.

Authors:  Andrea M Gunawan; Con-Ning Yen; Brian T Richert; Allan P Schinckel; Alan L Grant; David E Gerrard
Journal:  J Anim Sci       Date:  2020-11-01       Impact factor: 3.159

7.  Changes in myosin and creatine kinase mRNA levels with cardiac hypertrophy and hypothyroidism.

Authors:  G T Schuyler; L R Yarbrough
Journal:  Basic Res Cardiol       Date:  1990 Sep-Oct       Impact factor: 17.165

8.  Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway.

Authors:  P Costelli; C García-Martínez; M Llovera; N Carbó; F J López-Soriano; N Agell; L Tessitore; F M Baccino; J M Argilés
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 9.  Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.

Authors:  Oleg E Osadchii
Journal:  Heart Fail Rev       Date:  2007-03-27       Impact factor: 4.654

10.  Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm.

Authors:  Michael A Pearen; James G Ryall; Gordon S Lynch; George Eo Muscat
Journal:  BMC Genomics       Date:  2009-09-23       Impact factor: 3.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.